Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Bases de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Intensive Care Med ; 30(1): 68-74, 2004 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-14634726

RESUMEN

OBJECTIVE: To examine whether cytokine concentrations change in the pulmonary compartment during the development of ventilator-associated pneumonia (VAP). DESIGN: Non-directed bronchial lavage (NBL) was performed every 48 h in critically ill mechanically ventilated patients. Serial measurements of the cytokines tumor necrosis factor (TNF) alpha, interleukin (IL)-1alpha, IL-1beta, IL-6, and IL-10 and the cytokine inhibitors soluble TNFalpha receptor type I (sTNFalphaRI), IL-1 receptor antagonist (IL-1Ra) and soluble IL-1 receptor II (sIL-1RII) were performed on the NBL fluid and matching plasma samples by ELISA. SETTING: An adult medical and surgical university hospital intensive care unit. PATIENTS: Nine patients who developed VAP and nineteen patients who did not develop VAP served as controls. INTERVENTIONS: None. RESULTS: Plasma concentrations of the measured cytokines and cytokine inhibitors did not change significantly in any patients. In control patients, NBL fluid concentrations of sIL-1RII decreased significantly over time (P=0.01). In patients who developed VAP, NBL fluid concentrations of TNFalpha, sTNFalphaRI, IL-1alpha, and IL-1beta increased significantly (P=0.002, P=0.03, P=0.04 and P=0.02, respectively). Furthermore, NBL fluid/plasma concentration ratios for TNFalpha, sTNFalphaRI, IL-1alpha, IL-1Ra and IL-6 increased significantly as VAP developed (P=0.001, P=0.001, P=0.04, P=0.03, and P=0.04, respectively). CONCLUSION: Our results suggest that the production of important cytokines and cytokine inhibitors is compartmentalised within the lung in critically ill mechanically ventilated patients who develop VAP.


Asunto(s)
Líquido del Lavado Bronquioalveolar/citología , Citocinas/análisis , Citocinas/sangre , Neumonía Bacteriana/sangre , Neumonía Bacteriana/etiología , Respiración Artificial/efectos adversos , Adulto , Anciano , Antígenos CD/análisis , Antígenos CD/sangre , Compartimentos de Líquidos Corporales , Estudios de Casos y Controles , Citocinas/antagonistas & inhibidores , Citocinas/inmunología , Inglaterra , Ensayo de Inmunoadsorción Enzimática , Femenino , Hospitales Universitarios , Humanos , Proteína Antagonista del Receptor de Interleucina 1 , Interleucina-1/análisis , Interleucina-1/sangre , Interleucina-10/análisis , Interleucina-10/sangre , Interleucina-6/análisis , Interleucina-6/sangre , Modelos Lineales , Masculino , Persona de Mediana Edad , Neumonía Bacteriana/inmunología , Receptores de Interleucina-1/análisis , Receptores de Interleucina-1/sangre , Receptores Tipo I de Interleucina-1 , Receptores del Factor de Necrosis Tumoral/análisis , Receptores del Factor de Necrosis Tumoral/sangre , Receptores Tipo I de Factores de Necrosis Tumoral , Sialoglicoproteínas/análisis , Sialoglicoproteínas/sangre , Factores de Tiempo , Factor de Necrosis Tumoral alfa/análisis , Factor de Necrosis Tumoral alfa/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA